J 2024

Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study

STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER et. al.

Základní údaje

Originální název

Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study

Autoři

STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER, Antoinette Am ZEHNHOFF-DINNESEN, Rahel KUONEN, Annette WEISS, Tomáš KEPÁK, Jarmila KRUSEOVA, Claire BERGER, Gabriele CALAMINUS, Grit SOMMER a Claudia E KUEHNI

Vydání

JOURNAL OF CANCER SURVIVORSHIP, New York, SPRINGER, 2024, 1932-2259

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.700 v roce 2022

Organizační jednotka

Lékařská fakulta

UT WoS

001069959900001

Klíčová slova anglicky

Childhood cancer; Survivorship; Quality of life; Hearing loss; Tinnitus

Štítky

Změněno: 6. 3. 2024 09:21, Mgr. Tereza Miškechová

Anotace

V originále

PurposeAuditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL.MethodsWe included CCS from four European countries who were diagnosed at age & LE; 18 years; survived & GE; 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors.ResultsOur study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL.ConclusionWe observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors.Implications for cancer survivorsCCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.